For the quarter ended March 2025, Inseego (INSG) reported revenue of $31.67 million, down 29.6% over the same period last year. EPS came in at -$0.01, compared to -$0.36 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $32.07 million, representing a surprise of -1.23%. The company delivered an EPS surprise of +85.71%, with the consensus EPS estimate being -$0.07.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how ...

Thursday, May 8, 2025Markets rose today on hopeful sentiment regarding trade deals with U.S. partners, after an agreement with the UK that kept the baseline +10% tariff in place. The UK is far from the U.S.’s top trading partner, but the hope is that other deals will be coming down the pike in the coming days and weeks. The 90-day tariff suspension ends (at this point) on July 10th of this year.Whether more deals do land or they don’t, the Dow gained +254 points today, +0.62% (although it had been up +655 p ...

Yelp (YELP) reported $358.53 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 7.8%. EPS of $0.36 for the same period compares to $0.20 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $352.02 million, representing a surprise of +1.85%. The company delivered an EPS surprise of +16.13%, with the consensus EPS estimate being $0.31.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ...

Core Viewpoint - Hub Group reported a revenue of $915.22 million for the quarter ended March 2025, reflecting an 8.4% year-over-year decline and a surprise of -5.27% compared to the Zacks Consensus Estimate of $966.14 million [1] Group 1: Financial Performance - Earnings per share (EPS) for the quarter was $0.44, unchanged from the previous year, with an EPS surprise of +4.76% against the consensus estimate of $0.42 [1] - The company’s shares have returned -10.4% over the past month, contrasting with the Zacks S&P 500 composite's +11.3% change, indicating potential underperformance in the near term [3] Group 2: Revenue Breakdown - Operating Revenue from Intermodal and Transportation Solutions was $530.02 million, below the average estimate of $561.23 million, representing a year-over-year decline of 4% [4] - Operating Revenue from Inter-segment eliminations was -$25.81 million, better than the estimated -$28.63 million, but still reflecting a significant year-over-year change of -21.2% [4] - Operating Revenue from Logistics was $411 million, also below the average estimate of $446.60 million, marking a year-over-year decline of 14.4% [4]

Core Insights - McKesson reported revenue of $90.82 billion for the quarter ended March 2025, reflecting a 19% increase year-over-year, with EPS at $10.12 compared to $6.18 in the same quarter last year [1] - The revenue fell short of the Zacks Consensus Estimate of $93.7 billion by 3.08%, while the EPS exceeded the consensus estimate of $9.81 by 3.16% [1] Revenue Breakdown - U.S. Pharmaceutical revenue was $83.17 billion, a 20.9% increase year-over-year, but below the average estimate of $85.79 billion [4] - Prescription Technology Solutions revenue reached $1.34 billion, up 13.5% year-over-year, slightly below the average estimate of $1.36 billion [4] - International revenue was $3.46 billion, showing a year-over-year decline of 2.5%, compared to the average estimate of $3.55 billion [4] - Medical-Surgical Solutions revenue was $2.85 billion, a 0.6% increase year-over-year, exceeding the average estimate of $2.79 billion [4] Adjusted Operating Profit - Adjusted Operating Profit for U.S. Pharmaceutical was $1.05 billion, matching the average estimate [4] - Adjusted Operating Profit for International was $102 million, surpassing the average estimate of $96.42 million [4] - Adjusted Operating Profit for Corporate was -$165 million, slightly worse than the average estimate of -$160.18 million [4] - Adjusted Operating Profit for Prescription Technology Solutions was $285 million, exceeding the average estimate of $267.80 million [4] - Adjusted Operating Profit for Medical-Surgical Solutions was $285 million, slightly above the average estimate of $283.33 million [4] Stock Performance - McKesson's shares returned +7.5% over the past month, underperforming compared to the Zacks S&P 500 composite's +11.3% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

For the quarter ended March 2025, DoubleVerify Holdings (DV) reported revenue of $165.06 million, up 17.3% over the same period last year. EPS came in at $0.01, compared to $0.04 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $152.96 million, representing a surprise of +7.91%. The company delivered an EPS surprise of -50.00%, with the consensus EPS estimate being $0.02.While investors scrutinize revenue and earnings changes year-over-year and how they compare with W ...

For the quarter ended March 2025, Federal Realty Investment Trust (FRT) reported revenue of $309.15 million, up 6.1% over the same period last year. EPS came in at $1.70, compared to $0.66 in the year-ago quarter.The reported revenue represents a surprise of +0.72% over the Zacks Consensus Estimate of $306.93 million. With the consensus EPS estimate being $1.69, the EPS surprise was +0.59%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compar ...

For the quarter ended March 2025, Lyft (LYFT) reported revenue of $1.45 billion, up 13.5% over the same period last year. EPS came in at $0.19, compared to $0.15 in the year-ago quarter.The reported revenue represents a surprise of -0.96% over the Zacks Consensus Estimate of $1.46 billion. With the consensus EPS estimate being $0.20, the EPS surprise was -5.00%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next mo ...

Collegium Pharmaceutical (COLL) reported $177.76 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 22.7%. EPS of $1.49 for the same period compares to $1.45 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $172.45 million, representing a surprise of +3.08%. The company delivered an EPS surprise of +4.20%, with the consensus EPS estimate being $1.43.While investors scrutinize revenue and earnings changes year-over-year and how they compa ...

Westlake Corporation (WLK) reported a loss of $40 million or 31 cents per share for the first quarter of 2025. This compares to a profit of $174 million or $1.34 in the year-ago quarter. The bottom line missed the Zacks Consensus Estimate of earnings of 70 cents.Sales dipped around 4.3% year over year to $2,846 million in the quarter. It missed the Zacks Consensus Estimate of $2,920 million. The top line was impacted by a 2% decline in sales volumes and a 2% decline in average sales prices.The results in th ...